Sustained remission following autologous recovery after non-myeloablative stem cell transplantation in a patient with Hodgkin's lymphoma

被引：0
作者：
Martinez, Alexandre [1 ]
Xicoy, Blanca [1 ]
Ferra, Christelle [1 ]
Ribera, Josep-Maria [1 ]
机构：
[1] Univ Autonoma Barcelona, Hosp Univ Germans Trios & Pujol, Serv Hematol Clin, Inst Catala Oncol, E-08193 Barcelona, Spain
来源：
MEDICINA CLINICA | 2009年 / 132卷 / 18期
关键词：
HIGH-DOSE THERAPY; CONVENTIONAL THERAPY; DISEASE;
D O I：
10.1016/j.medcli.2008.04.007
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：723 / 724
页数：2
相关论文
共 10 条
[1]   Nonmyeloablative stem cell transplantation is an effective therapy for refractory or relapsed Hodgkin lymphoma:: Results of a Spanish prospective cooperative protocol [J].
Alvarez, I ;
Sureda, A ;
Caballero, MD ;
Urbano-Ispizzua, A ;
Ribera, JM ;
Canales, M ;
García-Conde, J ;
Sanz, G ;
Arranz, R ;
Bernal, MT ;
de la Serna, J ;
Díez, JL ;
Moraleda, JM ;
Rubió-Félix, D ;
Xicoy, B ;
Martínez, C ;
Mateos, MV ;
Sierra, J .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (02) :172-183
[2]  
André M, 1998, BLOOD, V92, P1933
[3]   Comparison of high-dose therapy and autologous stem-cell transplantation with conventional therapy for Hodgkin's disease induction failure:: A case-control study [J].
André, M ;
Henry-Amar, M ;
Pico, JL ;
Brice, P ;
Blaise, D ;
Kuentz, M ;
Coiffier, B ;
Colombat, P ;
Cahn, JY ;
Attal, M ;
Fleury, J ;
Milpied, N ;
Nedellec, G ;
Biron, P ;
Tilly, H ;
Jouet, JP ;
Gisselbrecht, C .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (01) :222-229
[4]   Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease [J].
Diehl, V ;
Franklin, J ;
Pfreundschuh, M ;
Lathan, B ;
Paulus, U ;
Hasenclever, D ;
Tesch, H ;
Herrmann, R ;
Dörken, B ;
Müller-Hermelink, H ;
Dühmke, E ;
Loeffler, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (24) :2386-2395
[5]   High-dose therapy and autologous stem-cell transplantation versus conventional therapy for patients with advanced Hodgkin's lymphoma responding to front-line therapy [J].
Federico, M ;
Bellei, M ;
Brice, P ;
Brugiatelli, M ;
Nagler, A ;
Gisselbrecht, C ;
Moretti, L ;
Colombat, P ;
Luminari, S ;
Fabbiano, F ;
Di Renzo, N ;
Goldstone, A ;
Carella, AM .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (12) :2320-2325
[6]   Bone marrow transplants from HLA-identical siblings in advanced Hodgkin's disease [J].
Gajewski, JL ;
Phillips, GL ;
Sobocinski, KA ;
Armitage, JO ;
Gale, RP ;
Champlin, RE ;
Herzig, RH ;
Hurd, DD ;
Jagannath, S ;
Klein, JP ;
Lazarus, HM ;
McCarthy, PL ;
Pavlovsky, S ;
Petersen, FB ;
Rowlings, PA ;
Russell, JA ;
Silver, SM ;
Vose, JM ;
Wiernik, PH ;
Bortin, MM ;
Horowitz, MM .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (02) :572-578
[7]   A prognostic score for advanced Hodgkin's disease [J].
Hasenclever, D ;
Diehl, V .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (21) :1506-1514
[8]   Reduced intensity allogeneic stem cell transplantation for Hodgkin's disease. Outcome depends primarily on disease status at the time of transplantation. [J].
Robinson, SP ;
Taghipour, G ;
Sureda, A .
BLOOD, 2004, 104 (11) :639A-639A
[9]   Autologous stem-cell transplantation for Hodgkin's disease:: Results and prognostic factors in 494 patients from the Grupo Espanol de Linfomas/Transplante Autolog de Medula Osea Spanish Cooperative Group [J].
Sureda, A ;
Arranz, R ;
Iriondo, A ;
Carreras, E ;
Lahuerta, JJ ;
García-Conde, J ;
Jarque, I ;
Caballero, MD ;
Ferrà, C ;
López, A ;
García-Laraña, J ;
Cabrera, R ;
Carrera, D ;
Ruiz-Romero, MD ;
León, A ;
Rifón, J ;
Díaz-Mediavilla, J ;
Mataix, R ;
Morey, M ;
Moraleda, JM ;
Altés, A ;
López-Guillermo, A ;
de la Serna, J ;
Fernández-Rañada, JM ;
Sierra, J ;
Conde, E .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (05) :1395-1404
[10]  
SUREDA A, 2003, BLOOD, V102, pA692
1